chr19-1220718-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000455.5(STK11):c.734+1G>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000455.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.734+1G>C | splice_donor_variant, intron_variant | Intron 5 of 9 | ENST00000326873.12 | NP_000446.1 | ||
STK11 | NM_001407255.1 | c.734+1G>C | splice_donor_variant, intron_variant | Intron 5 of 8 | NP_001394184.1 | |||
STK11 | NR_176325.1 | n.2001+1G>C | splice_donor_variant, intron_variant | Intron 6 of 10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.734+1G>C | splice_donor_variant, intron_variant | Intron 5 of 9 | 1 | NM_000455.5 | ENSP00000324856.6 | |||
STK11 | ENST00000652231.1 | c.734+1G>C | splice_donor_variant, intron_variant | Intron 5 of 8 | ENSP00000498804.1 | |||||
STK11 | ENST00000585748.3 | c.362+1G>C | splice_donor_variant, intron_variant | Intron 7 of 11 | 3 | ENSP00000477641.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.734+1G>C intronic pathogenic mutation results from a G to C substitution one nucleotide after coding exon 5 of the STK11 gene. Though this exact alteration has not been reported in the literature to our knowledge, a different alteration at the same location, c.734+1G>A (designated as IVS5+1G>A) was identified in a child diagnosed with JPS who had a history of hamartomatous polyps and perioral pigmentation (Olschwang S, J. Med. Genet. 2001 Jun; 38(6):356-60). This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice donor site; however, direct experimental evidence is unavailable. In addition to the clinical data presented in the literature, since alterations that disrupt the canonical splice donor site are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at